Translating Idiopathic pulmonary fibrosis guidelines into clinical practice
Author(s) -
Carlos Robalo Cordeiro,
António Morais
Publication year - 2020
Publication title -
pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.826
H-Index - 22
eISSN - 2531-0437
pISSN - 2531-0429
DOI - 10.1016/j.pulmoe.2020.05.017
Subject(s) - pulmonologists , medicine , idiopathic pulmonary fibrosis , pulmonology , pulmonologist , interstitial lung disease , nintedanib , intensive care medicine , family medicine , lung
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrotic interstitial lung disease of unknown cause, which predominantly manifests in older males. IPF diagnosis is a complex, multi-step process and delay in diagnosis cause a negative impact on patient survival. Additionally, a multidisciplinary team of pulmonologists, radiologists and pathologists is necessary for an accurate IPF diagnosis. The present study aims to assess how diagnosis and treatment of IPF are followed in Portugal, as well as the knowledge and implementation of therapeutic guidelines adopted by the Portuguese Society of Pulmonology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom